Thure Krarup

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon et al. · Diabetes · 2001 · 884 citations · Full text

Medicine, Endocrinology, Nutrition +16

Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus

Tina Vilsbøll, Thure Krarup, Jesper Sonne et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 523 citations

Life Sciences, Endocrinology, Physiology +17

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

T. Vilsb x F ll, Thure Krarup, Sten Madsbad et al. · Diabetologia · 2002 · 514 citations · Full text

Medicine, Endocrinology, Physiology +14

Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

Tina Vilsbøll, Milan Zdravkovic, T Le-Thi et al. · Diabetes Care · 2007 · 471 citations · Full text

Medicine, Endocrinology, Pharmacology +11

Similar Elimination Rates of Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients and Healthy Subjects

Tina Vilsbøll, Henrik Agersø, Thure Krarup et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 443 citations · Full text

Medicine, Endocrinology, Pharmacokinetics +9